Yokoyama C, Okamura H, Ibata Y
Department of Anatomy, Kyoto Prefectural University of Medicine, Japan.
Brain Res. 1995 May 29;681(1-2):153-9. doi: 10.1016/0006-8993(95)00308-d.
Dopamine D2-like receptor labeled by [3H]YM-09151-2 in the rat hippocampus proper was examined by in vitro receptor autoradiography. In the dorsal hippocampus, [3H]YM-09151-2 bindings were high in the whole layers of CA1, the stratum pyramidale of CA4 and the stratum molecular of gyrus dentatus, moderate in the stratum oriens of CA3 and hilus of the gyrus dentatus, and low in remaining CA3 and the subiculum. In the ventral hippocampus, the binding densities were high in the stratum oriens and the stratum radiatum of CA1, the stratum pyramidale of CA4, and the stratum moleculare of gyrus dentatus, moderate in the stratum lacnosum moleculare of CA1 and the hilus of the gyrus dentatus. Saturation analysis using hippocampal sections demonstrated that the Kd value was about five times higher than that using striatal sections. The rank order potency of competition on [3H]YM-09151-2 binding by dopaminergic ligands in the hippocampus was YM-09151-2 > (+)-butaclamol > dopamine > sulpiride > SCH-23390; which shows the appropriate dopamine D2-like receptor profile. The hippocampal [3H]YM-09151-2 binding did not represent serotonergic receptors (5-HT1A and 5-HT2) and sigma receptor, since Ki values of ketanserine, serotonin, 8-OH-DPAT and DTG were much lower than D2-like receptor antagonists. These findings suggest tha [3H]YM-09151-2 binds hippocampal D2-like receptor site with different association kinetics of striatal D2-like receptor site, and demonstrates widespread distribution of D2-like receptor in the hippocampus with distinct region-specific profile.
采用体外受体放射自显影技术检测大鼠海马体中由[3H]YM-09151-2标记的多巴胺D2样受体。在背侧海马体中,[3H]YM-09151-2结合在CA1的全层、CA4的锥体层和齿状回分子层中较高,在CA3的原层和齿状回的门区中中等,而在其余的CA3和下托中较低。在腹侧海马体中,结合密度在CA1的原层和辐射层、CA4的锥体层以及齿状回分子层中较高,在CA1的分子层腔隙层和齿状回门区中中等。使用海马体切片进行的饱和分析表明,解离常数(Kd)值比使用纹状体切片时高约五倍。多巴胺能配体对海马体中[3H]YM-09151-2结合的竞争效力顺序为YM-09151-2 > (+)-布他拉莫 > 多巴胺 > 舒必利 > SCH-23390;这显示出合适的多巴胺D2样受体特征。海马体中[3H]YM-09151-2结合并不代表5-羟色胺能受体(5-HT1A和5-HT2)和西格玛受体,因为酮色林、5-羟色胺、8-OH-DPAT和DTG的抑制常数(Ki)值远低于D2样受体拮抗剂。这些发现表明,[3H]YM-09151-2以与纹状体D2样受体位点不同的结合动力学与海马体D2样受体位点结合,并证明D2样受体在海马体中广泛分布且具有明显的区域特异性特征。